Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 22;5(11):ofy268.
doi: 10.1093/ofid/ofy268. eCollection 2018 Nov.

Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C

Kentaro Matsuura  1   2   3 , Nobuhiro Aizawa  4 , Hirayuki Enomoto  4 , Shuhei Nishiguchi  4 , Hidenori Toyoda  5 , Takashi Kumada  5 , Etsuko Iio  1   2 , Kyoko Ito  2 , Shintaro Ogawa  2 , Masanori Isogawa  2 , Harvey J Alter  3 , Yasuhito Tanaka  2
Affiliations

Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C

Kentaro Matsuura et al. Open Forum Infect Dis. .

Abstract

Background: Evaluating the progression of hepatic fibrosis in chronic hepatitis C (CHC) is critical, and identifying a predictive biomarker for fibrosis will be helpful for implementing personalized surveillance of hepatocellular carcinoma after the elimination of hepatitis C virus by antiviral therapy. This study aimed to investigate the association of circulating let-7a-5p levels with severity of hepatic fibrosis.

Methods: We analyzed circulating let-7a-5p levels in serum and serum-derived extracellular vesicles (EVs) in 84 Japanese CHC patients who underwent a liver biopsy by quantitative real-time polymerase chain reaction, and investigated the association of its levels with histological hepatic fibrotic stage, liver stiffness, and several hepatic fibrotic markers.

Results: The levels of let-7a-5p in serum and EVs were significantly lower in patients with liver cirrhosis. Additionally, the serum let-7a-5p level correlated significantly with hepatic fibrotic markers, Mac-2 binding protein glycan isomer (M2BPGi), fibrosis-4 (FIB-4) index, aspartate aminotransferase-to-platelet ratio index (APRI), and liver stiffness, evaluated by transient elastography. Furthermore, the serum let-7a-5p level was superior to M2BPGi, FIB-4, and APRI and was comparable to liver stiffness in discriminating liver cirrhosis.

Conclusions: These results provide evidence that circulating let-7a-5p in serum may serve as a surrogate marker for severity of hepatic fibrosis in CHC.

Keywords: extracellular vesicles; hepatic fibrosis; hepatitis C virus; let-7; microRNA.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Correlations between serum let-7a-5p levels and hepatic fibrosis severity. A, The levels of let-7a-5p in serum were compared between each group using the Mann-Whitney U test. B, Correlations between serum let-7a-5p levels and hepatic fibrotic markers using Spearman’s rank correlation coefficient (rho). Abbreviations: APRI, AST-to-platelet ratio index; AST, aspartate aminotransferase; COI, cutoff index; FIB-4, fibrosis-4; kPa, kilopascals; M2BPGi, Mac-2 binding protein glycan isomer.
See this image and copyright information in PMC

References

    1. Sterling RK, Lissen E, Clumeck N, et al. APRICOT Clinical Investigators Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43:1317–25. - PubMed
    1. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518–26. - PubMed
    1. Kuno A, Ikehara Y, Tanaka Y, et al. A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep 2013; 3:1065. - PMC - PubMed
    1. Kwok R, Tse YK, Wong GL, et al. Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease–the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther 2014; 39:254–69. - PubMed
    1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281–97. - PubMed